Therefore, this study aimed to thoroughly investigate the effects of chronic administration of an orally bioavailable CXCR4 antagonist on the pathogenic phenotypes such as abnormalities in blood and BM neutrophil levels, and infection susceptibility, in a pharmacologically induced CXCR2 LOF mouse model. This evidence concerns the gene CXCR2 and infection.